Amicus blueprints growth plans for Philly-based gene therapy group; Cash-strapped Compugen restructures, cuts 35 staffers
→ As Roche puts down its foot in Philadelphia as the base for its budding gene therapy operations built around new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
